LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Nur, U; Rachet, B; Parmar, MK; Sydes, MR; Cooper, N; Stenning, S; Read, G; Oliver, T; Mason, M; Coleman, MP (2012)
Publisher: Elsevier
Languages: English
Types: Article
Subjects:
BACKGROUND: Testicular cancer is the most common cancer in men under 35 years of age, and has the highest survival for adult male malignancies. Despite the fact that survival is very high, there is evidence that survival differs between socio-economic groups.
METHODS: We analysed survival patterns for 1606 testicular cancer patients diagnosed during 1984-2001 and recruited to one of two clinical studies. The first was a surveillance study to determine relapse-free survival after orchidectomy in 865 patients with stage I nonseminomatous germ-cell testicular cancer diagnosed during 1984-1991 (TE04). The second study was a trial in which 1174 men with stage I seminomatous germ-cell tumours were randomised to receive radiotherapy or one injection of carboplatin between 1996 and 2001 (TE19). The number of men available for analysis from these two studies was 578 and 1028, respectively. We followed these patients up for their vital status, and assigned them an ecological measure of deprivation. Crude and relative survival were estimated at 5 and 10 years by socio-economic deprivation.
RESULTS: No significant socio-economic gradient was seen: 1.3% (95% CI -0.3% to 3.1%) at 5 years and 2.1% (95% CI -0.5% to 4.7%) at 10 years.
CONCLUSION: We conclude that, given equal treatment at a given stage of disease, survival from testicular cancer does not depend on socio-economic status. This suggests that the socio-economic gradient in testicular cancer survival in the general population is more likely to be attributable to health care system factors than to personal or socio-economic factors in the men themselves.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • [1] Coleman MP, Rachet B, Woods LM et al. (2004) Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer 90: 1367-1373
    • [2] Kogevinas M, Porta M (1997) Socioeconomic differences in cancer survival: a review of the evidence. In: Social inequalities and cancer. (IARC Scientific Publications No. 138). Kogevinas M, Pearce N, Susser M, Boffetta P (eds) pp 177-206. International Agency for Research on Cancer: Lyon
    • [3] Coleman MP, Babb P, Mayer D, Quinn MJ, Sloggett A (1999) Cancer survival trends in England and Wales 1971-1995: deprivation and NHS region (CDROM). Office for National Statistics London, Office for National Statistics.
    • [4] Nur U, Rachet B, Mitry E, Cooper N, Coleman MP (2008) Survival from testicular cancer in England and Wales up to 2001. Br J Cancer 99: S80-S82
    • [5] Woods LM, Rachet B, Coleman MP (2006) Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol 17: 5-19
    • [6] Read G, Stenning SP, Cullen MH et al. (1992) Medical-Research-Council Prospective-Study of Surveillance for Stage-I Testicular Teratoma. Journal of Clinical Oncology 10: 1762-1768
    • [7] Oliver RTD, Mason MD, Mead GM et al. (2005) Radiotherapy versus singledose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet 366: 293-300
    • [8] Carstairs V (1995) Deprivation indices: their interpretation and use in relation to health. J Epidemiol Community Health 49: S3-S8
    • [9] Woods LM, Rachet B, Coleman MP (2005) Choice of geographic unit influences socioeconomic inequalities in breast cancer survival. Br J Cancer 92: 1279-1282
    • [10] Office of the Deputy Prime Minister (2004) The English Indices of deprivation 2004-summary (revised). http://www.communities.gov.uk/archived/publications/communities/indicesdepr ivation, accessed 21 Sep 2010
    • [11] National Assembly for Wales (2000) Welsh index of multiple deprivation. Cardiff, National Assembly for Wales
    • [12] Estève J, Benhamou E, Croasdale M, Raymond L (1990) Relative survival and the estimation of net survival: elements for further discussion. Stat Med 9: 529- 538
    • [13] Cancer Research UK Cancer Survival Group (2004) Life tables for England and Wales by sex, calendar period, region and deprivation. www.lshtm.ac.uk/ncdeu/cancersurvival/tools/strelandlifetables.htm, London School of Hygiene & Tropical Medicine.
    • [14] Grizzle JE, Starmer CF, Koch GG (1969) Analysis of categorical data by linear models. Biometrics 25: 489-504
    • [15] National Institute for Clinical Excellence (2002) Improving Outcomes in Urological Cancers: The manual. http://www.nice.org.uk/nicemedia/live/10889/28771/28771.pdf, accessed 27 Jul 11 A.D.
    • [16] Sorbye H, Pfeiffer P, Cavalli-Bjorkman N et al. (2009) Clinical Trial Enrollment, Patient Characteristics, and Survival Differences in Prospectively Registered Metastatic Colorectal Cancer Patients. Cancer 115: 4679-4687 0 . 0 0
    • ts % 1 n
    • t 6 0
    • o . 6 o 1 3
    • . 3 o
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article